Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Scribe Therapeutics
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Company
Organization
B2X
B2B
CEO
Benjamin L. Oakes
0
Company Operating Status
Active
Country
United States
0
Crunchbase URL
crunchbase.com/organiz...apeutics
DUNS Number
080990723
Email Address
bd@scribetx.com
0
info@scribetx.com
0
media@scribetx.com
0
Founded Date
2017
Founder
Jennifer Doudna
0
Brett T. Staahl
0
David F. Savage
0
Benjamin L. Oakes
0
Full Address
1150 Marina Village Pkwy, Alameda, CA 94501, United States
0
Industry
Regenerative medicine
Life science
Therapeutics
Molecular biology
Biomedical engineering
Genetics
Genomics
Technology
Biology
Biotechnology
•••
Investors
Andreessen Horowitz (a16z)
Key People
Richard Hector
0
Svetlana Lucas
0
Latest Funding Round Date
April 2021
Latest Funding Type
Series A
LinkedIn URL
@company/scribe-therapeutics/about
Location
Berkeley, California
San Francisco
Alameda, California
0
San Francisco Bay Area
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...433088-29
Technologies Used
CRISPR
Total Funding Amount (USD)
120,000,002
Twitter URL
@scribetx
Official Website
scribetx.com
Find more companies like Scribe Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE